Article
Mutations compensating for the fitness cost of rifampicin resistance in Escherichia coli exert pleiotropic effect on RNA polymerase catalysis.
Nucleic acids research - 10 Jun 2022
Kurepina Natalia, Chudaev Maxim, Kreiswirth Barry N, Nikiforov Vadim, Mustaev Arkady
Abstract excerpt
The spread of drug-resistant bacteria represents one of the most significant medical problems of our time. Bacterial fitness loss associated with drug resistance can be counteracted by acquisition of secondary mutations, thereby enhancing the virulence of such bacteria. Antibiotic rifampicin (Rif) targets cellular RNA polymerase (RNAP). It is potent broad spectrum drug used for treatment of bacterial infections....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
